![Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncprheum0424/MediaObjects/41584_2007_Article_BFncprheum0424_Fig1_HTML.jpg)
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
![Frontiers | Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives Frontiers | Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives](https://www.frontiersin.org/files/Articles/1024068/fimmu-13-1024068-HTML/image_m/fimmu-13-1024068-g001.jpg)
Frontiers | Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
![Frontiers | A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis Frontiers | A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis](https://www.frontiersin.org/files/Articles/803175/fimmu-12-803175-HTML/image_m/fimmu-12-803175-g001.jpg)
Frontiers | A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
![The proposed mechanisms of action for rituximab, a chimeric monoclonal... | Download Scientific Diagram The proposed mechanisms of action for rituximab, a chimeric monoclonal... | Download Scientific Diagram](https://www.researchgate.net/publication/230831937/figure/fig1/AS:203082278412288@1425429996137/The-proposed-mechanisms-of-action-for-rituximab-a-chimeric-monoclonal-antibody-against.png)
The proposed mechanisms of action for rituximab, a chimeric monoclonal... | Download Scientific Diagram
![Rituximab is a monoclonal antibody that recognises the transmembrane... | Download Scientific Diagram Rituximab is a monoclonal antibody that recognises the transmembrane... | Download Scientific Diagram](https://www.researchgate.net/publication/51710669/figure/fig1/AS:203058224078848@1425424261041/Rituximab-is-a-monoclonal-antibody-that-recognises-the-transmembrane-receptor-CD20-on-B.png)
Rituximab is a monoclonal antibody that recognises the transmembrane... | Download Scientific Diagram
![Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL- Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma | JCO Global Oncology Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL- Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma | JCO Global Oncology](https://ascopubs.org/cms/10.1200/JGO.19.00248/asset/images/large/jgo.19.00248f1.jpeg)
Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL- Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma | JCO Global Oncology
![Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL - James D'Rozario, Samuel K. Bennett, 2019 Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL - James D'Rozario, Samuel K. Bennett, 2019](https://journals.sagepub.com/cms/10.1177/2040620719844697/asset/images/large/10.1177_2040620719844697-fig2.jpeg)
Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL - James D'Rozario, Samuel K. Bennett, 2019
![Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram](https://www.researchgate.net/publication/221924296/figure/fig3/AS:667588631744528@1536176941819/Mechanism-of-action-of-rituximab-Rituximab-is-a-monoclonal-antibody-directed-against.png)
Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram
![Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fcc11304/MediaObjects/13054_2012_Article_703_Fig1_HTML.jpg)
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
![Rituximab Monoclonal Antibody Drug. Targets CD20 on B-lymphocytes Stock Illustration - Illustration of antibody, biotech: 186810711 Rituximab Monoclonal Antibody Drug. Targets CD20 on B-lymphocytes Stock Illustration - Illustration of antibody, biotech: 186810711](https://thumbs.dreamstime.com/z/rituximab-monoclonal-antibody-drug-targets-cd-b-lymphocytes-indications-use-indicate-rheumatoid-arthritis-number-186810711.jpg)
Rituximab Monoclonal Antibody Drug. Targets CD20 on B-lymphocytes Stock Illustration - Illustration of antibody, biotech: 186810711
Anticorps monoclonal anti-CD20 (rituximab) dans les maladies hématologiques et les affections auto-immunes Monoclonal anti-CD20
![Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/57302335-10b7-4e3f-b402-4d25811a8f1f/ajt_1288_f3.gif)